rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-9-4
|
pubmed:abstractText |
Some rectal cancers respond well to preoperative neoadjuvant therapy while others are inherently resistant or develop resistance during the treatment. To understand the mechanism underlying these differences, several markers that might be prognostic or predictive of downstaging in response to chemoradiotherapy in patients with rectal cancer were evaluated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Osteopontin,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/celecoxib
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0167-8140
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
172-7
|
pubmed:meshHeading |
pubmed-meshheading:16905208-Adult,
pubmed-meshheading:16905208-Aged,
pubmed-meshheading:16905208-Cyclooxygenase 2,
pubmed-meshheading:16905208-Female,
pubmed-meshheading:16905208-Fluorouracil,
pubmed-meshheading:16905208-Humans,
pubmed-meshheading:16905208-Immunohistochemistry,
pubmed-meshheading:16905208-Interleukin-6,
pubmed-meshheading:16905208-Ki-67 Antigen,
pubmed-meshheading:16905208-Male,
pubmed-meshheading:16905208-Membrane Proteins,
pubmed-meshheading:16905208-Middle Aged,
pubmed-meshheading:16905208-Neoadjuvant Therapy,
pubmed-meshheading:16905208-Osteopontin,
pubmed-meshheading:16905208-Preoperative Care,
pubmed-meshheading:16905208-Prognosis,
pubmed-meshheading:16905208-Pyrazoles,
pubmed-meshheading:16905208-Rectal Neoplasms,
pubmed-meshheading:16905208-Sulfonamides,
pubmed-meshheading:16905208-Tumor Markers, Biological
|
pubmed:year |
2006
|
pubmed:articleTitle |
Molecular responses of rectal cancer to preoperative chemoradiation.
|
pubmed:affiliation |
Department of Radiation Oncology and Experimental Radiation, Leuven Cancer Institute, University Hospital Leuven, Belgium. annelies.debucquoy@med.kuleuven.be <annelies.debucquoy@med.kuleuven.be>
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|